Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank64
3Y CAGR-10.9%
5Y CAGR+19.1%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-10.9%/yr
vs +88.5%/yr prior
5Y CAGR
+19.1%/yr
Recent deceleration
Acceleration
-99.4pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 20.71% | -45.3% |
| 2024 | 37.89% | +1.6% |
| 2023 | 37.29% | +27.3% |
| 2022 | 29.29% | +14.9% |
| 2021 | 25.48% | +195.3% |
| 2020 | 8.63% | -65.9% |
| 2019 | 25.27% | +989.9% |
| 2018 | 2.32% | -53.2% |
| 2017 | 4.95% | -58.6% |
| 2016 | 11.97% | - |